NLRP3 and gout: Targeting NLRP3 through potentially effective drugs such as natural products, novel compounds, and non-coding RNAs (ncRNAs) for the treatment of mouse models of MSU-induced gouty arthritis may be important for the treatment of gouty arthritis (33).